Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations | Nature Communications
Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity - ScienceDirect
Expression of KRas and apoptosis associated proteins in PDAC cell... | Download Scientific Diagram
Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations | Nature Communications
Establishment of a novel human cell line retaining the characteristics of the original pancreatic adenocarcinoma, and evaluation of MEK as a therapeutic target
Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer
Effects of KYA1797K on PDAC cell lines. (A) PDAC cell lines were... | Download Scientific Diagram
Novel Pancreatic Cancer Cell Lines Derived from Genetically Engineered Mouse Models of Spontaneous Pancreatic Adenocarcinoma: Applications in Diagnosis and Therapy | PLOS ONE
CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer | Journal of Experimental & Clinical Cancer Research | Full Text
Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity - ScienceDirect
IJMS | Free Full-Text | The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3β in Pancreatic Cancer | HTML
Cancers | Free Full-Text | Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer | HTML
IJMS | Free Full-Text | The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3β in Pancreatic Cancer
Cancers | Free Full-Text | Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer | HTML
CRISPR/Cas9-Mediated Knock-Out of KrasG12D Mutated Pancreatic Cancer Cell Lines
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
Cancers | Free Full-Text | CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer | HTML
Cancers | Free Full-Text | CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer | HTML
Development of a unique mouse model for pancreatic cancer lymphatic metastasis
Frontiers | Pre-clinical Models of Metastasis in Pancreatic Cancer